MediaAusBiotech Journal | Intellectual Property Feature29 Sep 20200Patrys appeared in a feature article in Ausbiotech’s journal, Australasian Biotechnology , in September 2020. The article titled, “Timing is…
News UpdateBioshares | September 202028 Sep 20200Patrys was featured in the latest issue of BioShares in an article titled, “Major Cancer Deals in DNA Damage Repair”.…
News UpdateArticle | Understanding the BBB9 Sep 20200In this article, Patrys CEO and MD Dr James Campbell compares historical access to a medieval town to the unique…
News UpdateBioshares | September 20207 Sep 20200Patrys was featured in the latest issue of BioShares in an article titled, “Janssen Shows Interest in SLE Antibodies”. Read…
NewsletterNewsletter | July 202022 Jul 20200Patrys is pleased to share its latest Newsletter, published July 2020. Key highlights: Letter From Our CEO Media and Analyst…
News UpdateBioshares | July 202020 Jul 20200Patrys was featured in the latest issue of BioShares in an article titled, “Patrys – Synthetic Lethality to Kill Cancer…
MediaHealth Kick Podcast | With Tim Boreham7 May 20200Health and Biotech expert, Tim Boreham, interviewed Patrys CEO and MD, Dr James Campbell, for the Health Kick Podcast. Listen…
News UpdateArticle | DDR therapeutics22 Apr 20200Patrys CEO and MD, Dr James Campbell, has written an article titled “DDR therapeutics and synthetic lethality – a precise…
News UpdateArticle | AstraZeneca20 Apr 20200AstraZeneca has published an article titled, “Combatting cancer by exploiting the DNA Damage Response.” Read it here.
NewsletterNewsletter | June 20191 Jun 20190Patrys is pleased to share its latest Newsletter, published June 2019. Key highlights: Letter from our CEO Progress with PAT-DX1…